Assessment of Negative Training on the Use of Cubicle Beds by Heifers

40 in-calf heifers were observed to examine the effect of timbers placing in passage area on their use of cubicle beds. Prior to the experiment preliminary observation was taken on these 40 heifers and they were divided into two even groups (cubicle user(or control) group versus cubicle refusal (or experimental) group by whether they properly used the cubicle beds or not. The timbers were placed in passage and feeding areas for the cubicle refusal group to force the animls to lie in the cubicle beds. The results of this experiment showed that feeding behaviour was unaffected by the presence of the timbers, but lying acitvity was about 8% higher for the experimental group, which led to a mean of almost 2 hours longer lying time over 24 h. After the timbers were removed, there was a significant decline in lying by the experimental group. The diurnal pattern of lying behaviour in cubicles indicated that the major effect on lying activity exerted by the presence of the timbers was seen during midnight to 10:00 a     

The parasympatholytic effects of atropine sulfate and glycopyrrolate in rats and rabbits.

Nine groups of rats (n = 5 per group) received an intramuscular (IM) injection of one of the following drugs or drug combinations: saline, atropine (0.05 mg/kg), glycopyrrolate (0.5 mg/kg), ketamine:xylazine (85:15 mg/kg), ketamine:detomidine (60:10 mg/kg), atropine:ketamine:xylazine (0.05: 85:15 mg/kg), glycopyrrolate: ketamine:xylazine (0.5:85:15 mg/kg), atropine:ketamine:detomidine (0.05: 60:10 mg/kg) or glycopyrrolate: ketamine:detomidine (0.5:60:10). Similarly six groups of rabbits (n = 5) received an IM injection of either saline, atropine (0.2 mg/kg), atropine (2 mg/kg), glycopyrrolate (0.1 mg/kg), ketamine:xylazine (35:10 mg/kg) or glycopyrrolate:ketamine:xylazine (0.1:35:10 mg/kg). In rats, atropine sulfate (0.05 mg/kg) and glycopyrrolate (0.5 mg/kg) produced an increase in heart rate for 30 and 240 min, respectively. In rabbits atropine sulfate at either 0.2 or 2.0 mg/kg did not induce a significant increase in heart rate, but glycopyrrolate (0.1 mg/kg) elevated the heart rate above saline treated animals for over 50 min. Both atropine and glycopyrrolate provided protection against a decrease in heart rate in rats anesthetized with ketamine: xylazine (85:15 mg/kg) or ketamine: detomidine (60:10 mg/kg); however, glycopyrrolate was significantly more effective in maintaining the heart rate within the normal range. Glycopprrolate also prevented a decrease in heart rate in rabbits anesthetized with ketamine:xylazine (35:5 mg/kg). Neither glycopyrrolate nor atropine influenced respiration rate, core body temperature or systolic blood pressure when used alone or when combined with the injectable anesthetic. Glycopyrrolate is an effective anticholinergic agent in rabbits and rodents and more useful as a preanesthetic agent than atropine sulfate in these animals.     

几种造林措施对墨西哥柏、银荆保存率及生长的影响

在呈贡劣质山地对墨西哥柏、银荆树植树造林进行了不同整地方式、植塘规格、种植密度、抚育方式的试验。结果：撩壕整地和水平台地的保存率及幼树生长量优于块状整地，且在阴坡深草地段尤为显著。３种植塘规格（６０ｃｍ×６０ｃｍ×６０ｃｍ，５０ｃｍ×５０ｃｍ×５０ｃｍ，４０ｃｍ×４０ｃｍ×４０ｃｍ）对墨西哥柏的保存率和高、径生长差异不显著，对银荆差异极显著，大塘优于小塘。３种种植密度（１．５ｍ×１．５ｍ，１．５ｍ×２ｍ，２ｍ×２ｍ），对幼林期的高、径生长及冠幅大小无显著影响，在３０°以上的陡坡，台地抚育优于菱形、扇形、块状抚育，与对照比较，４种抚育方式与之差异极显著。     

中国葡萄野生种对葡萄根癌病的抗性

通过田间接种鉴定，系统研究了中国葡萄属１３个种和变种的２６个株系对葡萄根癌病的抗性，筛选出高抗株系１０个。其中燕山葡萄（♀）因扦插容易生根，可用自根苗作为抗葡萄根癌病砧木进行嫁接试验，其余可用作抗葡萄根癌病的育种资源     

SH系砧木及对应中间砧红富士苹果枝条水分输导阻力研究

为进一步揭示砧木的矮化机理 ,以SH系矮化砧木及相应中间砧红富士苹果为试材 ,在生长季测定砧木枝条及嫁接部位的水分输导阻力。结果表明 ,SH系砧木枝条及嫁接部位的水分输导阻力 ,随砧木矮化程度的升高而增大 ,表明水分输导阻力的增加 ,是导致嫁接树矮化的原因之一。     

In vivo kinetic study on uptake and distribution of intramuscular tritium-labeled polysulfated glycosaminoglycan in equine body fluid compartments and articular cartilage in an osteochondrial defect model

The uptake and distribution of intramuscularly (IM) administered tritium-labeled polysulfated glycosaminoglycan (³H-PSGAG) in serum, synovial fluid, and articular cartilage of eight horses was quantitated, and hyaluronic acid (HA) concentration of the middle carpal joint was evaluated in a pharmacokinetic study. A full-thickness articular cartilage defect, created on the distal articular surface of the left radial carpal bone of each horse served as an osteochondral defect model. ³H-PSGAG (500 mg) was injected IM, between 14 and 35 days after creation of the defects. Scintillation analysis of serum and synovial fluid, collected from both middle carpal joints at specific predetermined times up to 96 hours post-injection, revealed mean ³H-PSGAG concentrations peaked at 2 hours post-injection. ³H-PSGAG was detected in cartilage and subchondral bone 96 hours post-injection in samples from all eight horses. There were no statistically significant differences in ³H-PSGAG concentration of synovial fluid or cartilage between cartilage defect and control (right middle carpal) joints.

HA assay of synovial fluid revealed concentrations significantly increased at 24, 48, and 96 hours post-injection in both joints. The concentration nearly doubled 48 hours post-injection. However, no statistically significant differences were found between synovial concentrations of HA in cartilage defect and control joints.

³H-PSGAG administered IM to horses, was distributed in the blood, synovial fluid, and articular cartilage. HA concentrations in synovial fluid increased after IM administration of polysulfated glycosaminoglycan.     

Laboratory diagnosis and disease occurrence in the current African swine fever eradication program in Spain, 1989–1991

The purpose of this study was to determine the rate of decline and geographical distribution by municipality of clinical and subclinical African swine fever (ASF) in the affected areas of Spain. A second aim was to evaluate the performance of diagnostic tests in the Spanish ASF eradication program. Clinical outbreaks were confirmed using both the direct and indirect immunofluorescence test (and if both were negative, by the hemabsorption test). The serological status of swine was determined by an enzyme-linked immunosorbent assay (ELISA) and suspect serum samples were confirmed by the immunoblot assay.

The number of clinical outbreaks (herds) of ASF for 1989, 1990 and 1991 was 170, 347 and 207, respectively. The numbers of municipalities within each affected province experiencing acute outbreaks for the same time periods were 49, 69 and 48, respectively. Serologically diagnosed animals positive for ASF were 1.1% of animals tested in 1989, 0.5% in 1990 and 0.8% in 1991. The corresponding positive predictive values of the standard ELISA test used were 99.0, 97.9 and 98.8, respectively. Similarly, the number of municipalities within each affected province experiencing serologically positive subclinically infected animals was 269, 178 and 147 for each of the years 1989, 1990 and 1991, respectively.